enkephalin, leucine has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunnett, SB; Sirinathsinghji, DJ | 2 |
2 other study(ies) available for enkephalin, leucine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): reversal by embryonic nigral dopamine grafts.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Enkephalins; Female; Fetal Tissue Transplantation; Neural Pathways; Nucleic Acid Hybridization; Protein Precursors; Rats; Rats, Inbred Strains; RNA, Messenger; Substantia Nigra | 1991 |
Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Dopamine; Embryo, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Substantia Nigra | 1989 |